ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2945

Incident Hand OA Is Strongly Associated with Reduced Peripheral Blood Leukocyte Telomere Length

Timothy E. McAlindon1, Mary Roberts2, Lena Franziska Schaefer3, Jeffrey B. Driban4, Jeffrey Duryea3, Francisco J Blanco5, Jose-Luis Fernandez-Garcia6 and Charles Eaton7, 1Division of Rheumatology, Tufts Medical Center, Boston, MA, 2Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Pawtucket, RI, 3Radiology, Brigham & Women's Hospital/ Harvard Medical School, Boston, MA, 4Rheumatology, Tufts Medical Center, Boston, MA, 5Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña. España, A Coruña, Spain, 6Genetic Department, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 7Family Medicine and Epidemiology, Warren Alpert Medical School, School of Public Health, Brown University, Providence, RI

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Aging, OA, Senescent Cells, Telomeres and hand disorders

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 8, 2017

Title: Osteoarthritis – Clinical Aspects II: Structural Progression and Incidence

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Hand OA (HOA) is a painful, destructive and deforming polyarticular disorder that impairs an individual’s ability to perform manipulative activities of daily life and has a strong association with increasing age. Telomeres are specialized chromatin structures at the end of linear eukaryotic chromosomes that perform a capping function, protecting chromosomes from degradation, recombination, and fusion between chromosomes. After each round of DNA replication there is a progressive loss of terminal telomere sequences, so telomeres progressively shorten with ageing in replicating somatic cells. There is also evidence that telomeric structure may be damaged as a result of oxidative stress. Ultimately, the telomeric sequence array may become critically shortened and trigger replicative senescence or apoptosis, contributing to processes related to aging. Peripheral blood leukocyte (PBL) telomere length is a biomarker for biological age and longevity. Data from cross-sectional studies are conflicting on whether telomere length is shorter in subjects with OA.

Methods: This used a convenience sample of Caucasian participants in the Osteoarthritis Initiative who had right hand x-rays at 0 and month 48; and PBL telomere length measured at baseline using real-time quantitative PCR. We defined interphalangeal OA (IPOA) as KL ≥2 in a finger or thumb joint (excluding thumb-base); and incidence if KL score increased from ≤1 to ≥2. We defined symptomatic IPOA as KL≥2 in ≥1 joint on 2 different fingers and report of hand pain (“During the past 30 days, pain, aching or stiffness on most days”) after baseline. We analyzed the standardized log of telomere length as a predictor for OA incidence at a joint level and across all joints using generalized linear mixed models to control for confounders and account for within-person correlation among joints.

Results: 275 participants were eligible for the analysis (mean baseline age 59.1y [s.d.8.7], 56.7% female, BMI 27.4 Kgm-2[4.4], 39 [14.2%] physician-diagnosed hand OA). 494 joints had OA at baseline and 47 developed incident IPOA. Prevalent IPOA at baseline was cross-sectionally associated with older age (OR=2.2; 95% CI 1.8, 2.6) and shorter telomere length (OR=1.3; 1.1, 1.6) but not with gender or BMI (all mutually adjusted). In prospective analyses with adjustment for age, BMI and gender, shorter telomere length predicted IPOA incidence in a joint (OR=1.5, 1.07, 2.1 -i.e. for every s.d. decrease in log of telomere length there is 50% increase in the likelihood of OA incidence); and the increase in number of affected joints (β=0.06, p=0.02), as well as incidence of symptomatic IPOA (OR=1.7, 1.1, 2.7). This association was consistent in the smaller subset without HOA at baseline (OR=1.7, 0.99, 2.8).

Conclusion: Shorter PBL telomere length is strongly and independently associated with prevalent and incident OA in finger joints and development of symptomatic IPOA. This may indicate an accelerated ageing phenotype associated with impaired chondrocyte function and capacity of cartilage and joint structures to maintain health and respond to biomechanical and inflammatory/metabolic stressors, leading to OA.


Disclosure: T. E. McAlindon, None; M. Roberts, None; L. F. Schaefer, None; J. B. Driban, NIAMS-NIH, 2,AXSOME Therapeutics, Inc., 5; J. Duryea, None; F. J. Blanco, Pfizer Inc, 5; J. L. Fernandez-Garcia, None; C. Eaton, None.

To cite this abstract in AMA style:

McAlindon TE, Roberts M, Schaefer LF, Driban JB, Duryea J, Blanco FJ, Fernandez-Garcia JL, Eaton C. Incident Hand OA Is Strongly Associated with Reduced Peripheral Blood Leukocyte Telomere Length [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/incident-hand-oa-is-strongly-associated-with-reduced-peripheral-blood-leukocyte-telomere-length/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incident-hand-oa-is-strongly-associated-with-reduced-peripheral-blood-leukocyte-telomere-length/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology